Intercept Pharmaceuticals, Inc. (ICPT):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Intercept Pharmaceuticals, Inc. (ICPT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH138103FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Intercept Pharmaceuticals, Inc. (Intercept) is a biopharmaceutical company. It undertakes the development and commercialization of therapeutics for the treatment of chronic liver and intestinal diseases, by utilizing its proprietary bile acid chemistry. The company’s lead product candidate obeticholic acid (OCA) is a bile acid analog that binds to and induces activity in the farnesoid X receptor, which is used to treat chronic autoimmune liver disease. It is used in the treatment of diseases such as primary biliary cirrhosis (PBC), nonalcoholic steatohepatitis (NASH), alcoholic hepatitis and primary sclerosing cholangitis (PSC). Intercept’s other developmental pipeline products include INT-767, used in the treatment of fibrosis; and INT-777 is used to treat type 2 diabetes. It distributes its products in the US and Europe. Intercept is headquartered in New York, the US.

Intercept Pharmaceuticals, Inc. Key Recent Developments

Nov 14, 2013: Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results
Oct 01, 2013: Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting
Aug 13, 2013: Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results
Aug 05, 2013: Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference
Jul 01, 2013: Intercept Pharmaceuticals to Present at the JMP Securities Healthcare Conference

This comprehensive SWOT profile of Intercept Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intercept Pharmaceuticals, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Intercept Pharmaceuticals, Inc. – Key Information
Intercept Pharmaceuticals, Inc. – Overview
Intercept Pharmaceuticals, Inc. – Key Employees
Intercept Pharmaceuticals, Inc. – Key Employee Biographies
Intercept Pharmaceuticals, Inc. – Key Operational Heads
Intercept Pharmaceuticals, Inc. – Major Products and Services
Intercept Pharmaceuticals, Inc. – History
Intercept Pharmaceuticals, Inc. – Company Statement
Intercept Pharmaceuticals, Inc. – Locations And Subsidiaries
Intercept Pharmaceuticals, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Intercept Pharmaceuticals, Inc. – Business Description
Intercept Pharmaceuticals, Inc. – Corporate Strategy
Intercept Pharmaceuticals, Inc. – SWOT Analysis
SWOT Analysis – Overview
Intercept Pharmaceuticals, Inc. – Strengths
Intercept Pharmaceuticals, Inc. – Weaknesses
Intercept Pharmaceuticals, Inc. – Opportunities
Intercept Pharmaceuticals, Inc. – Threats
Intercept Pharmaceuticals, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Intercept Pharmaceuticals, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Intercept Pharmaceuticals, Inc., Key Information
Intercept Pharmaceuticals, Inc., Key Ratios
Intercept Pharmaceuticals, Inc., Share Data
Intercept Pharmaceuticals, Inc., Major Products and Services
Intercept Pharmaceuticals, Inc., History
Intercept Pharmaceuticals, Inc., Key Employees
Intercept Pharmaceuticals, Inc., Key Employee Biographies
Intercept Pharmaceuticals, Inc., Key Operational Heads
Intercept Pharmaceuticals, Inc., Other Locations
Intercept Pharmaceuticals, Inc., Subsidiaries
Intercept Pharmaceuticals, Inc., Key Manufacturing facilities
Intercept Pharmaceuticals, Inc., Key Competitors
Intercept Pharmaceuticals, Inc., SWOT Analysis
Intercept Pharmaceuticals, Inc., Ratios based on current share price
Intercept Pharmaceuticals, Inc., Annual Ratios
Intercept Pharmaceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Intercept Pharmaceuticals, Inc., Performance Chart
Intercept Pharmaceuticals, Inc., Ratio Charts

★海外企業調査レポート[Intercept Pharmaceuticals, Inc. (ICPT):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Republic Services, Inc.:企業の戦略・SWOT・財務分析
    SummaryRepublic Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Naval Group:戦略・SWOT・企業財務分析
    Naval Group - Strategy, SWOT and Corporate Finance Report Summary Naval Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Pentair plc (PNR):企業のM&A・提携動向(発電分野)
    Summary Pentair plc (Pentair) is an industrial manufacturing company. The company designs, manufactures, markets and services valves, automation and controls, fittings and actuators; water system products and solutions for filtration, separation and fluid process management; and products that guard …
  • Critical Outcome Technologies Inc. (COT)(製薬・医療分野):企業M&A動向
    Summary Critical Outcome Technologies Inc. (COTI) is a biotechnology company. The company offers disease specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. It discovers and develops small molecules for the treatment of serious di …
  • Hepacyl Therapeutics, SL(製薬・医療分野):企業M&A動向
    Summary Hepacyl Therapeutics, SL (Hepacyl Therapeutics) is a biotechnology company. It develops therapies that modulate the human immune system. The company’s pipeline product portfolio includes interapo, oncostatin M, P60 inhibitor peptide of Foxp3 and interferon alpha-5. Hepacyl Therapeutics’ inte …
  • Petrochemical Corporation of Singapore (Private) Limited:企業概要及び戦略的SWOT分析
    Petrochemical Corporation of Singapore (Private) Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • Mesiniaga Bhdの企業概要及び財務/SWOT分析
    Mesiniaga Bhd Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Mesiniaga Bhd annual and quarterly forecasts made by stock market experts. The report also enables direct compar …
  • World Heart Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' World Heart Corporation Mergers …
  • Aben Resources Ltd (ABN):企業の財務及び戦略的SWOT分析
    Summary Aben Resources Ltd. (Aben) is a mineral exploration company that explores and develops gold, silver, uranium and tungsten. The company offers products such as uranium, lithium, gold, silver, lead, zinc and copper. It undertakes projects such as yukon, selwyn recce NWT, mann lake project at e …
  • Belvedere S.A.:企業概要・SWOT・財務分析
    Summary Canadean's "Belvedere S.A. : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • OncoSec Medical Inc. (ONCS):企業のM&A・提携動向(医療機器分野)
    Summary OncoSec Medical Incorporated (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. The company offers treatment for diseases such as metastatic melanoma, head and neck cancer, and triple negative breast cancer. It provides platform suc …
  • Semper AB:企業の戦略・SWOT・財務分析
    SummarySemper AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - De …
  • Societe Generale S.A.:企業の戦略・SWOT・財務分析
    SummarySociete Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Swinton Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Swinton Group Limited Mergers a …
  • Star Navigation Systems Group Ltd.:企業の戦略・SWOT・財務分析
    Star Navigation Systems Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Star Navigation Systems Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • TelaDoc Inc (TDOC)-医療機器分野:企業M&A・提携分析
    Summary TelaDoc Inc (Teladoc) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold and flu sympto …
  • Express Scripts Holding Company (ESRX):企業の財務及び戦略的SWOT分析
    Express Scripts Holding Company (ESRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Pou Sheng International (Holdings), Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Pou Sheng International (Holdin …
  • Thai Plastic and Chemical Public Company Limited (TPC):企業概要、財務及び戦略的SWOT分析
    Summary Thai Plastic and Chemical Public Company Limited (TPC) is a chemical company. The company manufactures and distributes polyvinyl chloride polymer and finished plastic products. Its products include PVC suspension resin, paste resin, PVC compound, chemical, and others. TPC’s PVC paste resins …
  • Turkish Aerospace Industries, Inc.:企業の戦略・SWOT・財務分析
    SummaryTurkish Aerospace Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆